during the past few years , the availability of aztreonam ( a monobactam ) , imipenem ( a carbapenem ) , and newer cephalosporins within vitro activities comparable with aminoglycosides against many gram-negative bacilli , has stimulated a reassessment of the role of aminoglycosides in treating these infections .
C0020933
imipenem
C0006968
carbapenem